본문 바로가기
KERD
논문KCI 등재

Managing liver cirrhotic complications: Overview of esophageal and gastric varices

1

조회

0

다운로드

7

인용

0

참고문헌

키워드

초록

Managing liver cirrhosis in clinical practice is still a challenging problem as its progression is associated with serious complications, such as variceal bleeding that may increase mortality. Portal hypertension (PH) is the main key for the development of liver cirrhosis complications. Portal pressure above 10 mmHg, termed as clinically significant portal hypertension, is associated with formation of varices; meanwhile, portal pressure above 12 mmHg is associated with variceal bleeding. Hepatic vein pressure gradient measurement and esophagogastroduodenoscopy remain the gold standard for assessing portal pressure and detecting varices. Recently, non-invasive methods have been studied for evaluation of portal pressure and varices detection in liver cirrhotic patients. Various guidelines have been published for clinicians’ guidance in the management of esophagogastric varices which aims to prevent development of varices, acute variceal bleeding, and variceal rebleeding. This writing provides a comprehensive review on development of PH and varices in liver cirrhosis patients and its management based on current international guidelines and real experience in Indonesia.

Abstract

Managing liver cirrhosis in clinical practice is still a challenging problem as its progression is associated with serious complications, such as variceal bleeding that may increase mortality. Portal hypertension (PH) is the main key for the development of liver cirrhosis complications. Portal pressure above 10 mmHg, termed as clinically significant portal hypertension, is associated with formation of varices; meanwhile, portal pressure above 12 mmHg is associated with variceal bleeding. Hepatic vein pressure gradient measurement and esophagogastroduodenoscopy remain the gold standard for assessing portal pressure and detecting varices. Recently, non-invasive methods have been studied for evaluation of portal pressure and varices detection in liver cirrhotic patients. Various guidelines have been published for clinicians’ guidance in the management of esophagogastric varices which aims to prevent development of varices, acute variceal bleeding, and variceal rebleeding. This writing provides a comprehensive review on development of PH and varices in liver cirrhosis patients and its management based on current international guidelines and real experience in Indonesia.

참고문헌 (74)

  1. Pinzani M, "Liver cirrhosis", Best Pract Res Clin Gastroenterol, 25, pp.281~290 (2011)
  2. Mokdad AA, "Liver cirrhosis mortality in 187 countries between 1980 and 2010 : a systematic analysis", BMC Med, 12, pp.145~ (2014)
  3. GBD 2017 Cirrhosis Collaborators, "The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017 : a systematic analysis for the Global Burden of Disease Study 2017", Lancet Gastroenterol Hepatol, 5, pp.245~266 (2020)
  4. D’Amico G, "Natural history and prognostic indicators of survival in cirrhosis : a systematic review of 118 studies", J Hepatol, 44, pp.217~231 (2006)
  5. de Franchis R, "Expanding consensus in portal hypertension: report of Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension", J Hepatol, 63, pp.743~752 (2015)
  6. Samonakis DN, "Clinical outcomes of compensated and decompensated cirrhosis : a long term study", World J Hepatol, 6, pp.504~512 (2014)
  7. Pellicoro A, "Liver fibrosis and repair : immune regulation of wound healing in a solid organ", Nat Rev Immunol, 14, pp.181~194 (2014)
  8. Elpek GÖ, "Angiogenesis and liver fibrosis", World J Hepatol, 7, pp.377~391 (2015)
  9. Iwakiri Y, "Pathophysiology of portal hypertension", Clin Liver Dis, 18, pp.281~291 (2014)
  10. Miñano C, "Clinical pharmacology of portal hypertension", Gastroenterol Clin North Am, 39, pp.681~695 (2010)
  11. Procopet B, "Diagnosis of cirrhosis and portal hypertension:imaging, non-invasive markers of fibrosis and liver biopsy", Gastroenterol Rep (Oxf), 5, pp.79~89 (2017)
  12. Suk KT, "Revision and update on clinical practice guideline for liver cirrhosis", Korean J Hepatol, 18, pp.1~21 (2012)
  13. Bolognesi M, "Clinical role of non-invasive assessment of portal hypertension", World J Gastroenterol, 23, pp.1~10 (2017)
  14. Kim MY, "Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis", Hepatology, 56, pp.1053~1062 (2012)
  15. Bureau C, "Transient elastography accurately predicts presence of significant portal hypertension in patients with chronic liver disease", Aliment Pharmacol Ther, 27, pp.1261~1268 (2008)
  16. Maruyama H, "Pathophysiology of portal hypertension and esophageal varices", Int J Hepatol, 2012, pp.895787~ (2012)
  17. Patel B, "Richard Schatzki : a familiar ring", AJR Am J Roentgenol, 201, pp.W678~W682 (2013)
  18. Abby Philips C, "historical aspects, classification and grading : everything in one place", Gastroenterol Rep(Oxf), 4, pp.186~195 (2016)
  19. Garcia-Tsao G, "Prevention and management of gastroesophageal varices and variceal hemorrhage in cirrhosis", Hepatology, 46, pp.922~938 (2007)
  20. Philips CA, "A comprehensive review of portosystemic collaterals in cirrhosis : historical aspects, anatomy, and classifications", Int J Hepatol, 2016, pp.6170243~ (2016)
  21. Ashkenazi E, "Evaluation and treatment of esophageal varices in the cirrhotic patient", Isr Med Assoc J, 15, pp.109~115 (2013)
  22. Yoshida H, "Risk factors for bleeding esophagogastric varices", J Nippon Med Sch, 80, pp.252~259 (2013)
  23. 박의주, "The Risk Factors for Bleeding of Fundal Varices in Patients with Liver Cirrhosis", Gut and Liver, 7(6), pp.704~711 (2013), 거트앤리버 소화기연관학회협의회
  24. Garcia-Tsao G, "Portal hypertensive bleeding in cirrhosis : risk stratification, diagnosis, and management : 2016 practice guidance by the American Association for the Study of Liver Diseases", Hepatology, 65, pp.310~335 (2017)
  25. Sarin SK, "Primary prophylaxis of gastroesophageal variceal bleeding : consensus recommendations of the Asian Pacific Association for the Study of the Liver", Hepatol Int, 2, pp.429~439 (2008)
  26. Sarin SK, "Diagnosis and management of acute variceal bleeding : Asian Pacific Association for Study of the Liver recommendations", Hepatol Int, 5, pp.607~624 (2011)
  27. European Association for the Study of the Liver, "EASL clinical practice guidelines for the management of patients with decompensated cirrhosis", J Hepatol, 69, pp.406~460 (2018)
  28. The Korean Association for the Study of the Liver, "KASL clinical practice guidelines for liver cirrhosis: Varices, hepatic encephalopathy, and related complications", Clinical and Molecular Hepatology, 26(2), pp.83~127 (2020), 대한간학회[DOI]
  29. Tajiri T, "General rules for recording endoscopic findings of esophagogastric varices(2nd edition)", Dig Endosc, 22, pp.1~9 (2010)
  30. Brick IB, "One thousand cases of portal cirrhosis of the liver. Implications of esophageal varices and their management", Arch Intern Med, 113, pp.501~511 (1964)
  31. Sarin SK, "Prevalence, classification and natural history of gastric varices : a long-term follow-up study in 568 portal hypertension patients", Hepatology, 16, pp.1343~1349 (1992)
  32. Karatzas A, "Non-invasive screening for esophageal varices in patients with liver cirrhosis", Ann Gastroenterol, 31, pp.305~314 (2018)
  33. Lee HA, "Prediction of the varices needing treatment with non-invasive tests in patients with compensated advanced chronic liver disease", Liver Int, 39, pp.1071~1079 (2019)
  34. Wang AJ, "Utility of endoscopic ultrasound in the diagnosis and management of esophagogastric varices", Endosc Ultrasound, 5, pp.218~224 (2016)
  35. Ge PS, "The changing role of beta-blocker therapy in patients with cirrhosis", J Hepatol, 60, pp.643~653 (2014)
  36. Groszmann RJ, "Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis", N Engl J Med, 353, pp.2254~2261 (2005)
  37. Sarin SK, "Early primary prophylaxis with beta-blockers does not prevent the growth of small esophageal varices in cirrhosis : a randomized controlled trial", Hepatol Int, 7, pp.248~256 (2013)
  38. Qi XS, "Nonselective betablockers in cirrhotic patients with no or small varices : a metaanalysis", World J Gastroenterol, 21, pp.3100~3108 (2015)
  39. Kumar A, "Can non-selective beta-blockers(NSBBs)prevent enlargement of small esophageal varices in patients with cirrhosis? A metaanalysis", J Clin Exp Hepatol, 7, pp.275~283 (2017)
  40. Bhardwaj A, "Carvedilol delays the progression of small oesophageal varices in patients with cirrhosis : a randomised placebocontrolled trial", Gut, 66, pp.1838~1843 (2017)
  41. Sharma M, "Comparison of therapies for primary prevention of esophageal variceal bleeding : a systematic review and network meta-analysis", Hepatology, 69, pp.1657~1675 (2019)
  42. Malandris K, "Carvedilol for prevention of variceal bleeding : a systematic review and meta-analysis", Ann Gastroenterol, 32, pp.287~297 (2019)
  43. Funakoshi N, "Meta-analysis : beta-blockers versus banding ligation for primary prophylaxis of esophageal variceal bleeding", Ann Hepatol, 11, pp.369~383 (2012)
  44. Mishra SR, "Primary prophylaxis of gastric variceal bleeding comparing cyanoacrylate injection and beta-blockers : a randomized controlled trial", J Hepatol, 54, pp.1161~1167 (2011)
  45. Tayyem O, "Evaluation and management of variceal bleeding", Dis Mon, 64, pp.312~320 (2018)
  46. Odutayo A, "Restrictive versus liberal blood transfusion for gastrointestinal bleeding : a systematic review and meta-analysis of randomised controlled trials", Lancet Gastroenterol Hepatol, 2, pp.354~360 (2017)
  47. Chavez-Tapia NC, "Meta-analysis : antibiotic prophylaxis for cirrhotic patients with upper gastrointestinal bleeding-an updated cochrane review", Aliment Pharmacol Ther, 34, pp.509~518 (2011)
  48. Gin-Ho Lo, "The Use of vasoconstrictors in Acute variceal Bleeding: How long Is Enough?", Clinical Endoscopy, 52(1), pp.36~39 (2019), 대한소화기내시경학회[DOI]
  49. Ioannou GN, "Systematic review : terlipressin in acute oesophageal variceal haemorrhage", Aliment Pharmacol Ther, 17, pp.53~64 (2003)
  50. Seo YS, "Lack of difference among terlipressin, somatostatin, and octreotide in the control of acute gastroesophageal variceal hemorrhage", Hepatology, 60, pp.954~963 (2014)
  51. Zhou X, "Terlipressin for the treatment of acute variceal bleeding: a systematic review and meta-analysis of randomized controlled trials", Medicine (Baltimore), 97, pp.e13437~ (2018)
  52. Garcia-Pagán JC, "Management of gastric varices", Clin Gastroenterol Hepatol, 12, pp.919~928 (2014)
  53. Tan PC, "A randomized trial of endoscopic treatment of acute gastric variceal hemorrhage : N-butyl-2-cyanoacrylate injection versus band ligation", Hepatology, 43, pp.690~697 (2006)
  54. Kochhar GS, "Comparative study of endoscopy vs. transjugular intrahepatic portosystemic shunt in the management of gastric variceal bleeding", Gastroenterol Rep(Oxf), 3, pp.75~82 (2015)
  55. Lv Y, "Early TIPS with covered stents versus standard treatment for acute variceal bleeding in patients with advanced cirrhosis : a randomised controlled trial", Lancet Gastroenterol Hepatol, 4, pp.587~598 (2019)
  56. McCarty TR, "Self-expanding metal stents for acute refractory esophageal variceal bleeding : a systematic review and metaanalysis", Dig Endosc, 28, pp.539~547 (2016)
  57. 장세영, "Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study", Clinical and Molecular Hepatology, 18(4), pp.368~374 (2012), 대한간학회[DOI]
  58. Keiji Yokoyama, "Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal", gastric varices in Child-Pugh class C end-stage liver cirrhosis, 2019, pp.25(2), 183~189[DOI]
  59. Wang ZW, "Comparison of the effects of TIPS versus BRTO on bleeding gastric varices : a meta-analysis", Can J Gastroenterol Hepatol, 2020, pp.5143013~ (2020)
  60. Ibrahim M, "Early application of haemostatic powder added to standard management for oesophagogastric variceal bleeding : a randomised trial", Gut, 68, pp.844~853 (2019)
  61. Ibrahim M, "Management of acute variceal bleeding using hemostatic powder", United European Gastroenterol J, 3, pp.277~283 (2015)
  62. Ge PS, "Successful EUS-guided treatment of gastric varices with coil embolization and injection of absorbable gelatin sponge", VideoGIE, 4, pp.154~156 (2019)
  63. Ravipati M, "Pharmacotherapy plus endoscopic intervention is more effective than pharmacotherapy or endoscopy alone in the secondary prevention of esophageal variceal bleeding : a meta-analysis of randomized, controlled trials", Gastrointest Endosc, 70, pp.658~664 (2009)
  64. Puente A, "Drugs plus ligation to prevent rebleeding in cirrhosis : an updated systematic review", Liver Int, 34, pp.823~833 (2014)
  65. Holster IL, "Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy + β-blocker for prevention of variceal rebleeding", Hepatology, 63, pp.581~589 (2016)
  66. Qi X, "Covered TIPS for secondary prophylaxis of variceal bleeding in liver cirrhosis: a systematic review and meta-analysis of randomized controlled trials", Medicine (Baltimore), 95, pp.e5680~ (2016)
  67. Boregowda U, "Update on the management of gastrointestinal varices", World J Gastrointest Pharmacol Ther, 10, pp.1~21 (2019)
  68. Yeon Seok Seo, "Prevention and management of gastroesophageal varices", Clinical and Molecular Hepatology, 24(1), pp.20~42 (2018), 대한간학회
  69. Lee HA, "Prognosis of patients with gastric variceal bleeding after endoscopic variceal obturation according to the type of varices", Eur J Gastroenterol Hepatol, 31, pp.211~217 (2019)
  70. Mishra SR, "Endoscopic cyanoacrylate injection versus beta-blocker for secondary prophylaxis of gastric variceal bleed : a randomised controlled trial", Gut, 59, pp.729~735 (2010)
  71. Lo GH, "A prospective, randomized controlled trial of transjugular intrahepatic portosystemic shunt versus cyanoacrylate injection in the prevention of gastric variceal rebleeding", Endoscopy, 39, pp.679~685 (2007)
  72. Lesmana CRA, "Clinical significance of isolated gastric varices in liver cirrhotic patients : a single-referral-centre retrospective cohort study", JGH Open, 4, pp.511~518 (2019)
  73. Kalista KF, "Clinical profile of cirrhotic patient with esophageal varices who undergo band ligation in Cipto Mangunkusumo Hospital", J Penyakit Dalam Indones, 6, pp.36~41 (2019)
  74. Hasan I, "Non-invasive predictors of moderate-large esophageal varices in compensated cirrhotic patients", Am J Gastroenterol, 114(Supplement), pp.S572~ (2019)

관련 논문AI추천

Prevention and management of gastroesophageal varicesYeon Seok Seo대한간학회 · Clinical and Molecular Hepatology2018 · 제24권 제1호The Use of vasoconstrictors in Acute variceal Bleeding: How long Is Enough?Gin-Ho Lo대한소화기내시경학회 · Clinical Endoscopy2019 · 제52권 제1호Endoscopic Therapy and Radiologic Intervention of Acute Gastroesophageal Variceal Bleeding송정은, Byung Seok Kim대한소화기내시경학회 · Clinical Endoscopy2019 · 제52권 제5호Change in Portal Pressure and Clinical Outcome in Cirrhotic Patients with Gastric Varices after Plug-Assisted Retrograde Transvenous Obliteration김상균, Cheon Gab Jin, Jang Jae Young, Jeong Soung Won, Jun Baek Gyu, Kim Hong Soo, Kim Young Don, Kim Young Seok, Lee Jae Myung, Lee Sae Hwan, Park Jae Woo, Shim Jong Joon, Yoo Jeong-Ju거트앤리버 소화기연관학회협의회 · Gut and Liver2020 · 제14권 제6호Endoscopic treatment or balloon-occluded retrograde transvenous obliteration is safe for patients with esophageal/gastric varices in Child-Pugh class C end-stage liver cirrhosisDaisuke Morihara, Hideo Kunimoto, Hiromi Fukuda, Kazuhide Takata, Keiji Yokoyama, Kumiko Shibata, Ryo Yamauchi, Satoshi Shakado, Shinjiro Inomata, Shotaro Sakisaka, Takashi Tanaka, Yasuaki Takeyama대한간학회 · Clinical and Molecular Hepatology2019 · 제25권 제2호Relationship between the hepatic venous pressure gradient and first variceal hemorrhage in patients with cirrhosis: a multicenter retrospective study in Korea김동준, 김문영, 김상균, 김영석, 김홍수, 백순구, 석기태, 이세환, 장재영, 정승원, Boo Sung Kim, Ho Eun Jung, Jin Nyoung Kim, Kyoung Min Sohn대한간학회 · Clinical and Molecular Hepatology2012 · 제18권 제4호

이 간행물의 다른 논문 (39건)